Cargando…

Corrigendum: Association of CT-based delta radiomics biomarker with progression-free survival in patients with colorectal liver metastases undergo chemotherapy

Detalles Bibliográficos
Autores principales: Ye, Shuai, Han, Yu, Pan, XiMin, Niu, KeXin, Liao, YuTing, Meng, XiaoChun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545842/
https://www.ncbi.nlm.nih.gov/pubmed/37795439
http://dx.doi.org/10.3389/fonc.2023.1283480
_version_ 1785114748480651264
author Ye, Shuai
Han, Yu
Pan, XiMin
Niu, KeXin
Liao, YuTing
Meng, XiaoChun
author_facet Ye, Shuai
Han, Yu
Pan, XiMin
Niu, KeXin
Liao, YuTing
Meng, XiaoChun
author_sort Ye, Shuai
collection PubMed
description
format Online
Article
Text
id pubmed-10545842
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-105458422023-10-04 Corrigendum: Association of CT-based delta radiomics biomarker with progression-free survival in patients with colorectal liver metastases undergo chemotherapy Ye, Shuai Han, Yu Pan, XiMin Niu, KeXin Liao, YuTing Meng, XiaoChun Front Oncol Oncology Frontiers Media S.A. 2023-09-18 /pmc/articles/PMC10545842/ /pubmed/37795439 http://dx.doi.org/10.3389/fonc.2023.1283480 Text en Copyright © 2023 Ye, Han, Pan, Niu, Liao and Meng https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Ye, Shuai
Han, Yu
Pan, XiMin
Niu, KeXin
Liao, YuTing
Meng, XiaoChun
Corrigendum: Association of CT-based delta radiomics biomarker with progression-free survival in patients with colorectal liver metastases undergo chemotherapy
title Corrigendum: Association of CT-based delta radiomics biomarker with progression-free survival in patients with colorectal liver metastases undergo chemotherapy
title_full Corrigendum: Association of CT-based delta radiomics biomarker with progression-free survival in patients with colorectal liver metastases undergo chemotherapy
title_fullStr Corrigendum: Association of CT-based delta radiomics biomarker with progression-free survival in patients with colorectal liver metastases undergo chemotherapy
title_full_unstemmed Corrigendum: Association of CT-based delta radiomics biomarker with progression-free survival in patients with colorectal liver metastases undergo chemotherapy
title_short Corrigendum: Association of CT-based delta radiomics biomarker with progression-free survival in patients with colorectal liver metastases undergo chemotherapy
title_sort corrigendum: association of ct-based delta radiomics biomarker with progression-free survival in patients with colorectal liver metastases undergo chemotherapy
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545842/
https://www.ncbi.nlm.nih.gov/pubmed/37795439
http://dx.doi.org/10.3389/fonc.2023.1283480
work_keys_str_mv AT yeshuai corrigendumassociationofctbaseddeltaradiomicsbiomarkerwithprogressionfreesurvivalinpatientswithcolorectallivermetastasesundergochemotherapy
AT hanyu corrigendumassociationofctbaseddeltaradiomicsbiomarkerwithprogressionfreesurvivalinpatientswithcolorectallivermetastasesundergochemotherapy
AT panximin corrigendumassociationofctbaseddeltaradiomicsbiomarkerwithprogressionfreesurvivalinpatientswithcolorectallivermetastasesundergochemotherapy
AT niukexin corrigendumassociationofctbaseddeltaradiomicsbiomarkerwithprogressionfreesurvivalinpatientswithcolorectallivermetastasesundergochemotherapy
AT liaoyuting corrigendumassociationofctbaseddeltaradiomicsbiomarkerwithprogressionfreesurvivalinpatientswithcolorectallivermetastasesundergochemotherapy
AT mengxiaochun corrigendumassociationofctbaseddeltaradiomicsbiomarkerwithprogressionfreesurvivalinpatientswithcolorectallivermetastasesundergochemotherapy